These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29408192)

  • 1. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
    Petkeviciene J; Ivanauskiene R; Klumbiene J
    Public Health; 2018 Mar; 156():79-86. PubMed ID: 29408192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.
    Kriaucioniene V; Petkeviciene J
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31744058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Breast and Cervical Cancer Screening Uptake Among Women in Turkey.
    Sözmen K; Unal B; Sakarya S; Dinc G; Yardim N; Keskinkilic B; Ergör G
    Asia Pac J Public Health; 2016 Sep; 28(6):528-38. PubMed ID: 27354286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
    Paulauskiene J; Ivanauskiene R; Skrodeniene E; Petkeviciene J
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500116
    [No Abstract]   [Full Text] [Related]  

  • 5. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization patterns of cervical cancer screening in Italy.
    Barbadoro P; Ricciardi A; Di Tondo E; Vallorani S; Mazzarini G; Prospero E
    Eur J Cancer Prev; 2015 Mar; 24(2):135-40. PubMed ID: 24977627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, attitudes, and practices regarding cervical cancer and screening among women visiting primary health care Centres in Bahrain.
    Jassim G; Obeid A; Al Nasheet HA
    BMC Public Health; 2018 Jan; 18(1):128. PubMed ID: 29325528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.
    Suurna M; Orumaa M; Ringmets I; Pärna K
    BMC Womens Health; 2022 Dec; 22(1):545. PubMed ID: 36566176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014.
    Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM
    Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the social gradients for Pap smears and mammograms in Argentina: evidence from the 2005 and 2009 National Risk Factor Surveys.
    De Maio FG; Linetzky B; Ferrante D
    Public Health; 2012 Oct; 126(10):821-6. PubMed ID: 23083845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
    Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
    BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.
    Broberg G; Wang J; Östberg AL; Adolfsson A; Nemes S; Sparén P; Strander B
    PLoS One; 2018; 13(1):e0190171. PubMed ID: 29320536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle and health-related predictors of cervical cancer screening attendance in a Swiss population-based study.
    Richard A; Rohrmann S; Schmid SM; Tirri BF; Huang DJ; Güth U; Eichholzer M
    Cancer Epidemiol; 2015 Dec; 39(6):870-6. PubMed ID: 26651449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013.
    Theme Filha MM; Leal MD; Oliveira EF; Esteves-Pereira AP; Gama SG
    Int J Equity Health; 2016 Nov; 15(1):136. PubMed ID: 27852313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.